Tag: Biologics
-
Biocon Biologics and Biocon to Merge: Key Developments in the Biopharmaceutical Sector
Biocon to acquire balance stake in Biocon Biologics at EV of USD 5.5 billion Biocon announced a strategic corporate action to fully integrate Biocon Biologics (BBL) as a wholly owned subsidiary into Biocon, subject to applicable approvals. The Strategy Committee, constituted in May 2025, undertook a comprehensive evaluation of multiple strategic options for Biocon Biologics,…
-
Biocon to Consolidate Biologics Division in $5.5 Billion Merger
Biocon Ltd will integrate Biocon Biologics Ltd as a wholly owned subsidiary in a deal valuing the unit at $5.5 billion, the company said on Saturday. Biocon will acquire the remaining stake in Biocon Biologics from Serum Institute Life Sciences, Tata Capital Growth Fund II and Activ Pine LLP via a share swap of 70.28…